AGP Executive Report
Last update: 7 hours agoAbortion Policy Clash in Liechtenstein: Hereditary Prince Alois says he will veto any move to legalise abortion in the first trimester, keeping the current strict rules (only allowed in cases like sexual assault or to protect the mother’s health), as about 40 women reportedly travel abroad each year for care. Cancer Drug Deal: IMPACT Therapeutics and Pharmanovia signed an exclusive licensing agreement for senaparib, aiming to expand access for ovarian, fallopian tube, and primary peritoneal cancer maintenance therapy across 66 countries, including Liechtenstein and much of Europe. Hepatitis B Hope: Researchers in Europe highlight progress toward a “functional cure” for chronic hepatitis B, noting millions in the EU/EEA (including Liechtenstein) live with the infection and often only learn after serious liver damage. Healthcare Data Breach: Brown Health Medical Group-MA says a December 2025 breach affected 311,000 people, with personal, medical, and financial details potentially exposed. Trade Pressure: The U.S. imposed new tariffs on Switzerland over forced-labour claims, escalating a dispute that could indirectly affect regional health and supply chains.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
